GGrantIndex
Sort

46,585 grants matching heart failure

Infrastructure for mentored access to CHS data and specimens

$1,372,795
Bruce M Psaty · University Of Washington · R01 · FY2025 · HL

Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)

$1,372,712
Wilbur A Lam · Emory University · U54 · FY2022 · EB

Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas

$1,370,677
Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2014 · HL

Cardiovascular Toxicity of Environmental Aldehydes

$1,369,195
Aruni Bhatnagar Bhatnagar · University Of Louisville · P01 · FY2007 · ES

Vascular Determinants of Stage B HF among Hispanics: the role of the Heart-Vascular Interaction

$1,368,103
Carlos Jose Rodriguez · Albert Einstein College Of Medicine · R01 · FY2022 · HL

Multiethnic Study of Breast Arterial Calcium Gradation and CVD

$1,365,927
Carlos Iribarren · Kaiser Foundation Research Institute · R01 · FY2014 · HL

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

$1,365,557
Jason D Christie · University Of Pennsylvania · U01 · FY2021 · HL

Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis

$1,364,939
Joao A C Lima · Johns Hopkins University · R01 · FY2025 · HL

Maryland Telehome Care Network (MTCN)

$1,364,245
Shiraz I Mishra · University Of Maryland Baltimore · RC2 · FY2009 · MD

Cardiovascular Toxicity of Environmental Aldehydes

$1,363,722
University Of Louisville · P01 · FY2004 · ES

Automation and validation of human on a chip systems for drug discovery

$1,363,424
Michael L Shuler · Hesperos, Llc · R44 · FY2018 · TR

Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2

$1,362,717
Andrea Z. Lacroix · University Of California, San Diego · R01 · FY2025 · HL

Development and Clinical Testing of CorAide RVAD/BVAD

$1,362,467
Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · HL

Look AHEAD: Action for Health Diabetes

$1,361,819
F. Xavier Pi-Sunyer · St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2012 · DK

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,361,114
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Multi-functional anti-thrombotic therapy for coronary microvascular obstruction

$1,360,862
Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2024 · HL

Black Church & CVD: Are we our brothers Keeper?

$1,359,457
Eugenia Eng · Univ Of North Carolina Chapel Hill · P60 · FY2008 · MD

Local Signals and Macromolecular Architecture in Heart

$1,359,179
University Of Maryland Baltimore · P01 · FY2002 · HL

Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.

$1,358,848
David A. Zidar · Case Western Reserve University · U01 · FY2020 · CA

IND-enabling safety and toxicity testing of a subcutaneous formulation of the PTP1B inhibitor MSI-1436, a novel strategy for treating fatal cardiomyopathy in Duchenne muscular dystrophy patients

$1,358,179
Kevin Strange · Revidia Therapeutics, Inc · R44 · FY2024 · HL

Immunobiology and immunotherapy of leukemia

$1,353,837
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

CHS Events Follow-up Study

$1,353,530
Bruce M Psaty · University Of Washington · U01 · FY2008 · HL

Dynamics Underlying Tissue Integrity

$1,353,508
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · DK

Drug Targeting, Testing, and Development

$1,353,502
Richard A. Miller · Translational Genomics Research Inst · U19 · FY2025 · AG

ASPirin in Reducing Events in the Elderly

$1,352,658
Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2013 · AG